BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

587 related articles for article (PubMed ID: 24186069)

  • 1. Exploiting endocytosis for nanomedicines.
    Akinc A; Battaglia G
    Cold Spring Harb Perspect Biol; 2013 Nov; 5(11):a016980. PubMed ID: 24186069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endocytosis of nanomedicines.
    Sahay G; Alakhova DY; Kabanov AV
    J Control Release; 2010 Aug; 145(3):182-95. PubMed ID: 20226220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocytosis and intracellular trafficking as gateways for nanomedicine delivery: opportunities and challenges.
    Duncan R; Richardson SC
    Mol Pharm; 2012 Sep; 9(9):2380-402. PubMed ID: 22844998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insights into cellular uptake of nanoparticles.
    Kafshgari MH; Harding FJ; Voelcker NH
    Curr Drug Deliv; 2015; 12(1):63-77. PubMed ID: 25146441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanomaterial designing strategies related to cell lysosome and their biomedical applications: A review.
    Rathore B; Sunwoo K; Jangili P; Kim J; Kim JH; Huang M; Xiong J; Sharma A; Yang Z; Qu J; Kim JS
    Biomaterials; 2019 Aug; 211():25-47. PubMed ID: 31078050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and Toxicological Considerations of Nanomedicines: The Future Directions.
    Patel P; Shah J
    Curr Clin Pharmacol; 2017; 12(2):73-82. PubMed ID: 28486906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nano based drug delivery systems: recent developments and future prospects.
    Patra JK; Das G; Fraceto LF; Campos EVR; Rodriguez-Torres MDP; Acosta-Torres LS; Diaz-Torres LA; Grillo R; Swamy MK; Sharma S; Habtemariam S; Shin HS
    J Nanobiotechnology; 2018 Sep; 16(1):71. PubMed ID: 30231877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parameters and characteristics governing cellular internalization and trans-barrier trafficking of nanostructures.
    Murugan K; Choonara YE; Kumar P; Bijukumar D; du Toit LC; Pillay V
    Int J Nanomedicine; 2015; 10():2191-206. PubMed ID: 25834433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanopharmaceuticals and nanomedicines currently on the market: challenges and opportunities.
    Farjadian F; Ghasemi A; Gohari O; Roointan A; Karimi M; Hamblin MR
    Nanomedicine (Lond); 2019 Jan; 14(1):93-126. PubMed ID: 30451076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanomedicines for Renal Management: From Imaging to Treatment.
    Jiang D; Rosenkrans ZT; Ni D; Lin J; Huang P; Cai W
    Acc Chem Res; 2020 Sep; 53(9):1869-1880. PubMed ID: 32786331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating Nanomedicines: Obstacles and Advancements.
    Swierczewska M; Crist RM; McNeil SE
    Methods Mol Biol; 2018; 1682():3-16. PubMed ID: 29039088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibacterial nanomedicine.
    Yacoby I; Benhar I
    Nanomedicine (Lond); 2008 Jun; 3(3):329-41. PubMed ID: 18510428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concepts of nanoparticle cellular uptake, intracellular trafficking, and kinetics in nanomedicine.
    Donahue ND; Acar H; Wilhelm S
    Adv Drug Deliv Rev; 2019 Mar; 143():68-96. PubMed ID: 31022434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Designing polymer conjugates as lysosomotropic nanomedicines.
    Duncan R
    Biochem Soc Trans; 2007 Feb; 35(Pt 1):56-60. PubMed ID: 17233601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brave new world revisited: Focus on nanomedicine.
    Fadeel B; Alexiou C
    Biochem Biophys Res Commun; 2020 Nov; 533(1):36-49. PubMed ID: 32921412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shape matters when engineering mesoporous silica-based nanomedicines.
    Hao N; Li L; Tang F
    Biomater Sci; 2016 Apr; 4(4):575-91. PubMed ID: 26818852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanomedicines for kidney diseases.
    Williams RM; Jaimes EA; Heller DA
    Kidney Int; 2016 Oct; 90(4):740-5. PubMed ID: 27292222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tunable resistive pulse sensing: potential applications in nanomedicine.
    Sivakumaran M; Platt M
    Nanomedicine (Lond); 2016 Aug; 11(16):2197-214. PubMed ID: 27480794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular delivery of siRNA and antisense oligonucleotides via receptor-mediated endocytosis.
    Ming X
    Expert Opin Drug Deliv; 2011 Apr; 8(4):435-49. PubMed ID: 21381985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in green nanoparticulate systems for drug delivery: efficient delivery and safety concern.
    Lam PL; Wong WY; Bian Z; Chui CH; Gambari R
    Nanomedicine (Lond); 2017 Feb; 12(4):357-385. PubMed ID: 28078952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.